Previous Close | 242.69 |
Open | 244.76 |
Bid | 232.50 x 900 |
Ask | 256.63 x 900 |
Day's Range | 240.95 - 245.00 |
52 Week Range | 132.24 - 246.80 |
Volume | |
Avg. Volume | 1,111,212 |
Market Cap | 35.728B |
Beta (5Y Monthly) | 0.66 |
PE Ratio (TTM) | 35.14 |
EPS (TTM) | 6.92 |
Earnings Date | Oct 24, 2024 - Oct 28, 2024 |
Forward Dividend & Yield | 2.12 (0.87%) |
Ex-Dividend Date | Aug 15, 2024 |
1y Target Est | 228.04 |
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, beginning at approximately 10:00 a.m. (Eastern Daylight Time) at the New York Marriott Marquis in New York, NY. More information about this event, including access to the live, audi
The S&P 500 added 0.2% on Tuesday, Aug. 27, ahead of Nvidia's earnings report on Wednesday and key economic data on tap for later in the week.